SKU: OPC-IPRALUNGS-2.5ML
Ipralungs Respules 2.5ML contains Levosalbutamol 1.25mg and Ipratropium 500mcg, a combination used through a nebulizer to help relax and widen the airways and improve breathing.
Ipralungs Respules 2.5ML is a prescription respiratory medicine containing Levosalbutamol 1.25mg and Ipratropium 500mcg. This combination is used through a nebulizer to help relax the muscles surrounding the airways, widen the breathing passages and make airflow easier.
Ipralungs combines two bronchodilator medicines that work through different mechanisms. Levosalbutamol helps relax the airway muscles, while Ipratropium reduces the action of acetylcholine on the airways. Together, they can help reduce symptoms such as wheezing, chest tightness, coughing and shortness of breath associated with obstructive airway conditions.
The medicine is generally used with a suitable nebulizer and should be used exactly as prescribed. It is important to follow the correct nebulization technique and not swallow the liquid contained in the respule.
For more respiratory-care products, explore our Respiratory Medicine Collection.
Ipralungs Respules 2.5ML is a combination bronchodilator formulation containing Levosalbutamol and Ipratropium. It is administered by inhalation through a nebulizer and is used to improve airflow in patients with certain obstructive airway conditions.
Levosalbutamol is a bronchodilator that stimulates beta-2 receptors in airway muscles and helps them relax. Ipratropium is an anticholinergic bronchodilator that reduces the action of acetylcholine on the airway muscles.
The combined action of these medicines can widen narrowed airways and make breathing easier. Ipralungs should be used only for the condition and duration recommended by a healthcare professional.
For reliable general information about respiratory medicines and health conditions, visit MedlinePlus.
Ipralungs may be prescribed for the management of breathing symptoms associated with chronic obstructive pulmonary disease (COPD). It helps relax and widen the airways, which can make breathing easier.
Narrowed airways can cause wheezing during breathing. The bronchodilator combination in Ipralungs can help open the airways and reduce wheezing when used as directed.
Ipralungs may help relieve breathlessness associated with reversible or partially reversible airway narrowing in conditions for which the medicine has been prescribed.
Airway narrowing may produce a sensation of tightness in the chest. By relaxing airway muscles and improving airflow, Ipralungs can help reduce this symptom in appropriate patients.
The combination of Levosalbutamol and Ipratropium is used to improve airflow when bronchospasm or airway narrowing contributes to breathing difficulty.
Ipralungs contains two bronchodilators that work together to relax airway muscles and widen the breathing passages.
By improving airflow through narrowed airways, Ipralungs may help reduce breathlessness and make breathing more comfortable.
Wheezing can occur when air moves through narrowed airways. The bronchodilator action of Ipralungs can help improve airway diameter and reduce wheezing.
Ipralungs can be included in a doctor's treatment plan for COPD to help manage symptoms related to airway obstruction.
The combination of Levosalbutamol and Ipratropium provides bronchodilation through two different mechanisms, which can provide greater airway relaxation than either mechanism alone in appropriate patients.
The medicine is inhaled through a nebulizer, allowing the active ingredients to reach the respiratory tract directly.
Each 2.5ML respule contains:
Other inactive ingredients may be present in the formulation. Refer to the product packaging for the complete list of ingredients.
Ipralungs contains two bronchodilators: Levosalbutamol and Ipratropium.
Levosalbutamol is a selective beta-2 adrenergic receptor agonist. It relaxes the smooth muscles surrounding the airways, helping the breathing passages become wider.
Ipratropium is an anticholinergic medicine. It blocks the action of acetylcholine at specific receptors in the airways, reducing bronchoconstriction and helping improve airflow.
Because the two medicines work through different mechanisms, their combined action can provide useful bronchodilation in appropriate respiratory conditions.
Ipralungs Respules should be used through a nebulizer exactly as directed by your doctor. Do not swallow the contents of the respule.
Wash your hands before preparing the nebulizer. Twist or remove the top of the respule according to the product instructions and squeeze the prescribed contents into the nebulizer chamber.
Use the solution immediately after opening the respule. Sit upright and breathe normally through the nebulizer mouthpiece or mask while the medicine is being delivered.
Clean the nebulizer equipment after use according to the manufacturer's instructions to maintain proper hygiene and medicine delivery.
The dose and frequency of Ipralungs depend on the patient's age, medical condition, severity of symptoms and response to treatment.
Use the exact amount and frequency prescribed by your doctor. Do not use additional respules simply because symptoms have not improved immediately.
If your breathing symptoms are not controlled with the prescribed treatment, contact your healthcare professional instead of increasing the dose yourself.
Ipralungs may cause dry mouth, cough, sore throat, headache, dizziness, tremors, nausea, stomach discomfort or changes in taste in some patients.
Some patients may experience palpitations, increased heart rate, muscle cramps or fatigue. These effects may be temporary, but persistent or troublesome symptoms should be discussed with a healthcare professional.
Rarely, inhaled bronchodilators can cause paradoxical bronchospasm, in which breathing suddenly becomes worse after inhalation. Seek immediate medical attention if this occurs.
Dry mouth is a possible side effect of Ipratropium-containing medicines. Drinking water regularly and maintaining good oral hygiene may help reduce discomfort.
If severe or persistent mouth dryness occurs, discuss it with your healthcare professional.
Avoid getting the nebulized solution into the eyes. Ipratropium may worsen eye symptoms in susceptible individuals, particularly those with narrow-angle glaucoma.
Seek medical advice if you develop eye pain, eye redness, blurred vision or halos around lights after accidental exposure.
If you are pregnant, planning pregnancy or think you may be pregnant, tell your doctor before using Ipralungs.
Your doctor will evaluate the expected benefits and potential risks before recommending treatment during pregnancy.
Tell your doctor if you are breastfeeding before starting Ipralungs. Your healthcare professional will determine whether the combination is suitable for you and provide appropriate advice.
Tell your doctor about all prescription medicines, over-the-counter medicines, inhalers, vitamins and supplements you are currently using.
Ipralungs may interact with other bronchodilators, anticholinergic medicines, certain heart medicines, diuretics, digoxin, MAO inhibitors and some antidepressant medicines.
Do not combine Ipralungs with another inhaled bronchodilator unless your doctor has specifically advised you to do so.
If you miss a scheduled dose of Ipralungs, use it when you remember unless it is nearly time for the next scheduled dose.
Do not use two doses at the same time to make up for a missed dose. If you frequently forget doses, discuss your treatment routine with your healthcare professional.
Ipralungs Respules 2.5ML is a combination bronchodilator containing Levosalbutamol 1.25mg and Ipratropium 500mcg. It is administered through a nebulizer.
Ipralungs is used to help manage breathing symptoms associated with airway narrowing, particularly in conditions such as COPD, when prescribed by a doctor.
Ipralungs contains Levosalbutamol 1.25mg and Ipratropium 500mcg in each 2.5ML respule.
Levosalbutamol relaxes airway muscles through beta-2 receptor stimulation, while Ipratropium reduces cholinergic bronchoconstriction. Together, they help widen the airways.
No. Ipralungs Respules are intended for inhalation through a nebulizer and should not be swallowed.
Yes. Dry mouth is a possible side effect, mainly associated with the Ipratropium component.
Yes. Tremors can occur in some patients because of the bronchodilator component. Contact your doctor if tremors are severe or persistent.
Palpitations or an increased heart rate can occur in some patients. Tell your doctor if you have heart disease or experience persistent or severe palpitations.
Tell your doctor if you are pregnant or planning pregnancy. Your doctor will determine whether the medicine is appropriate based on your individual circumstances.
Store Ipralungs according to the product label, generally in a cool and dry place below the recommended temperature. Keep the respules in their original packaging and away from children.
Explore our Respiratory Medicine Collection for additional products related to breathing and airway care.
For general medicine information, visit MedlinePlus.
This information is provided for general educational purposes and does not replace professional medical advice, diagnosis or treatment. Ipralungs Respules is a prescription medicine and should be used only according to the instructions of a qualified healthcare professional.
The dosage, frequency and duration of treatment depend on the patient's medical condition and response to therapy. Always follow your doctor's instructions and the product information supplied with the medicine.
| Brand | Ipralungs |
| Manufacturer | Mankind Pharma Ltd |
| Composition | Levosalbutamol 1.25mg |
| Package | 2.5 ml |
| Ship time | 5-10 Business Days |
Free Shipping
For all oders over $99
Secure Payment
100% secure payment
24/7 Support
Online top support